Macrophage Activation Syndrome as a Complication of Chronic Granulomatous Disease: A Case Report

Eduardo Liquidano-Perez1, Mariana Carmona Berrón2, Rosa Itzel Carrillo Nieto3

  • 1Immunology Service, National Institute of Pediatrics, Secretariat of Health Mexico, Mexico City, Mexico. eduardoliquidano@gmail.com.

Insights

Chronic granulomatous disease (CGD) can manifest as secondary hemophagocytic lymphohistiocytosis (HLH). Early diagnosis of this rare presentation is crucial for timely treatment and carrier identification.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by granuloma formation and recurrent infections.
  • CGD follows autosomal or X-linked recessive inheritance patterns.
  • Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome.

Observation:

  • A 10-month-old infant presented with fatal secondary HLH as the primary manifestation of CGD.
  • Autopsy revealed noncaseating granulomas, pulmonary aspergilloma, and hemophagocytosis.
  • Dihydrorhodamine (DHR) assay on maternal relatives indicated an X-linked CGD inheritance pattern.

Findings:

  • The patient was diagnosed with CGD complicated by macrophage activation syndrome (MAS), a form of secondary HLH.
  • CGD results from phagocyte dysfunction, leading to impaired pathogen control and granuloma development.
  • Secondary HLH involves excessive immune activation, characterized by macrophage and T-cell proliferation and cytokine release.

Implications:

  • Early recognition of CGD presenting as secondary HLH is critical for initiating appropriate treatment.
  • Identifying carriers through genetic studies aids in understanding CGD etiology and family counseling.
  • This case highlights the diverse clinical spectrum of CGD and the importance of considering it in infants with unexplained HLH.